SCHEMBL23633637

SCHEMBL23633637

c1ccc(Nc2cccc3oc4ccc5ccccc5c4c23)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.59
▸ HPGD P15428 3/20 0.59
▸ ATM Q13315 2/20 0.59
▸ TSHR P16473 2/20 0.59
▸ HSD17B10 Q99714 2/20 0.59
▸ TP53 P04637 2/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ ALOX15 P16050 1/20 0.59
▸ CDC25B P30305 1/20 0.59
▸ KDM4E B2RXH2 4/20 0.50
▸ TDP1 Q9NUW8 3/20 0.50
▸ MAPT P10636 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ GAA P10253 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ GLA P06280 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ FADS1 O60427 1/20 0.46
▸ TTR P02766 1/20 0.43
▸ FABP4 P15090 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23423609 0.91 AKR1C3 (0.51) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL23633536 0.89 ALDH1A1 (0.53) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL26538152 0.83 ALDH1A1 (0.71) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL29458820 0.83 ALDH1A1 (0.71) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL31123403 0.83 HPGD (0.49) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL30645483 0.83 ALDH1A1 (0.57) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL18471152 0.83 ALDH1A1 (0.57) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL23423894 0.82 ABCG2 (0.43) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL22506130 0.82 HPGD (0.56) ALDH1A1HPGDATMTSHRHSD17B10
SCHEMBL14133142 0.82 GAA (0.59) ALDH1A1HPGDATMTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331654-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-10-19 — — US disclosed
US-20230331654-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-10-19 — — US disclosed
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-13 — — US disclosed
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-13 — — US disclosed
US-20220131090-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 — — US disclosed
US-11063226-B1 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2021-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof ESR1, EML4, OCIAD2 ALDH1A1 757/4885HPGD 3551/4885ATM 2370/4885
US-20230331654-A1 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF OCIAD1, OCIAD2, ORAI2 ALDH1A1 2133/4885HPGD 1589/4885ATM 3523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback